Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Roza Hayduk"'
Autor:
Ilya Lipkovich, Christopher Carlson, Gopalan Sethuraman, Paul S. Aisen, Hong Liu-Seifert, Karen C. Holdridge, Sharon L. Hoog, Rachelle S. Doody, Roza Hayduk, Scott W. Andersen, Eric Siemers
Publikováno v:
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Introduction Solanezumab is an anti-amyloid monoclonal antibody in clinical testing for treatment of Alzheimer's disease (AD). Its mechanism suggests the possibility of slowing the progression of AD. Methods A possible disease-modifying effect of sol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f17efaf14455142c074ebfae1843f8
http://europepmc.org/articles/PMC5975050
http://europepmc.org/articles/PMC5975050
Publikováno v:
Psychopharmacology. 167:380-385
Modafinil is a first-line wake-promoting medication and a useful therapeutic alternative to psychostimulant medications for excessive daytime sleepiness.This 5-week, randomized, open-label study evaluated three strategies for switching patients from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5df83ea6b008e03b2093b5d5eb9a8aa5
https://doi.org/10.1007/s00213-002-1343-4
https://doi.org/10.1007/s00213-002-1343-4
Autor:
Tamsin L. Kelly, Alexandre Barbault, Daniel F. Kripke, Roza Hayduk, Boris Pasche, David Ryman
Publikováno v:
Stress Medicine. 13:251-258
Shift work and jet lag can disrupt circadian rhythms, with detrimental effects on alertness, performance and sleep. This study examined the effects of two interventions to adapt circadian rhythms, sleep and performance to a 10-h phase delay of the wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::692d7f2395a3311d5341a4b44e192dfb
https://doi.org/10.1002/(sici)1099-1700(199710)13:4<251::aid-smi750>3.0.co
https://doi.org/10.1002/(sici)1099-1700(199710)13:4<251::aid-smi750>3.0.co
Autor:
Alexandre Barbault, Niels Kuster, Martin Reite, Merrill M. Mitler, Lisa Higgs, Jean-Pierre Lebet, Claude Rossel, Roza Hayduk, Boris Pasche, David A. Amato, Milton K. Erman, Urania Dafni
Publikováno v:
Europe PubMed Central
The treatment of chronic psychophysiological insomnia presents a challenge that has not been met using currently available pharmacotherapy. Low energy emission therapy (LEET) has been developed as a potential alternative therapy for this disorder. LE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11eb1cbfa127f5ab8554788d29578d73
https://doi.org/10.1093/sleep/19.4.327
https://doi.org/10.1093/sleep/19.4.327
Autor:
Merrill M. Mitler, James C. Miller, Roza Hayduk, Denis F. Darko, Tamsin Kelly, Stephen J. Brown, Jeannine L. White
Publikováno v:
AIDS. 9:1043-1050
Objective : To repeat and extend findings suggesting that sleep disturbance, excessive daytime sleepiness, and degraded cognitive-motor abilities may be early markers of central nervous system (CNS) involvement in HIV infection. Design : A controlled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7c340c36843639112e9e62eba0e23e
https://doi.org/10.1097/00002030-199509000-00009
https://doi.org/10.1097/00002030-199509000-00009
Autor:
Thomas Roth, Gwendolyn E Niebler, Russell Rosenberg, Keith Wesnes, John R. Harsh, Roza Hayduk, Sanjay Arora, James K. Walsh
Publikováno v:
Current medical research and opinion. 22(4)
This study assessed the efficacy and safety of armodafinil, the longer half-life enantiomer of modafinil, for the treatment of excessive sleepiness in patients with narcolepsy.This was a multicenter double-blind study with 196 patients (aged 18-65 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::330ef12272d14ddcb06af907cb74e883
https://pubmed.ncbi.nlm.nih.gov/16684437
https://pubmed.ncbi.nlm.nih.gov/16684437
Publikováno v:
Sleep medicine. 1(1)
Background: Narcolepsy, a neurological disorder characterized by excessive daytime sleepiness and abnormal REM sleep, is known to be tightly associated with the human leukocyte antigen (HLA) DQB1*0602.Methods: In this study, baseline data collected f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8af6182370e176ab0475607fe9e90810
https://pubmed.ncbi.nlm.nih.gov/10733618
https://pubmed.ncbi.nlm.nih.gov/10733618
Publikováno v:
Sleep.
Narcolepsy is a sleep disorder associated with HLA DR15 (DR2) and DQB1*0602. We HLA typed 509 patients enrolled in a clinical trial for the drug modafinil and analyzed the results in relation to cataplexy, a symptom of narcolepsy characterized by mus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d23ff9acb9f40d4dff95e81bbdeb2022
https://doi.org/10.1093/sleep/20.11.1012
https://doi.org/10.1093/sleep/20.11.1012
Autor:
Eric Siemers, Joonmi Oh, Ann Marie Hake, Joyce Suhy, Roza Hayduk, Jerome Barakos, Christopher Carlson, Michael Case
Publikováno v:
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Introduction Solanezumab, a humanized monoclonal antibody that binds soluble amyloid beta peptide, is being developed for treatment of Alzheimer's disease (AD). Methods Patients (n = 2042) with mild and moderate AD were randomized 1:1 to 400-mg solan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba0a9f2300308ab4906f23a3e4cd5563